News

In this video interview, Mark Lebwohl, MD, explains the need and demand for the 2021 NP&PA Fall Clinical Dermatology Conference.

The 11th annual New Frontiers in Cosmetic Medicine and Medical Dermatology Conference starts today. Here’s what to look forward to.

From November 12 to 14 in Orlando, Florida, the 2021 PA&NP Fall Clinical Dermatology conference will be offering a multitude of informative sessions to educate the dermatology world.

While the COVID-19 pandemic has led to telehealth expansion, the question remains which expansions should continue.

The New Frontiers in Cosmetic Medicine and Medical Dermatology symposium is happening this weekend, November 12-14, in Hasbrouck Heights, New Jersey. Bruce Katz, MD, tells us what dermatologists have to gain from this event.

This week’s edition of The Mainstream Patient features stories about eczema on the eyelid, why rosacea is often misdiagnosed on darker skin and more!

A preview at what to expect from Dermatology Times this week.

Click here to answer this week's poll.

ICYMI, some of this week’s featured content includes an exclusive interview about hyperhidrosis, and articles on a new the ACAAI annual scientific meeting this weekend, clascoterone cream, and more.

Several doctors were recognized at the American College of Allergy, Asthma, & Immunology annual scientific meeting held November 4 to 8 in New Orleans, Louisiana.

In this episode, we dive into the background of the “The Full Spectrum of Dermatology: A Diverse and Inclusive Atlas.” Adam Friedman, MD, and Misty Eleryan MD, MS, describe their process to creating this new dermatologic resource.

In this video interview, Jeff Yu, MD, talks about what he's looking forward to at the 2021 American College of Allergy, Asthma & Immunology (ACAAI) annual scientific meeting.

Sessions with a laser focus on dermatologic issues ranging from new JAK inhibitors to disparities in atopic dermatitis anchor the opening day of the 2021 American College of Allergy, Asthma & Immunology (ACAAI) annual scientific meeting.

We sit down in a video interview with David Pariser, MD, FACP, FAAD, the secretary and founding member of the International Hyperhidrosis Society to discuss hyperhidrosis identifiers and treatments in honor of Hyperhidrosis Awareness Month.

This week’s edition of The Mainstream Patient features stories about back acne, things to avoid while scars are healing and more!

Click here to answer this weeks poll.

A preview at what to expect from Dermatology Times this week.

ICYMI, some of this week’s featured content includes an exclusive interview the NFCMMD symposium, and articles on ruxolitinib, what to watch in the psoriasis pipeline, and more.

The assumption has been that the COVID-19 pandemic has been at the root of recent upticks in physician burnout.

This week’s edition of The Mainstream Patient features stories about psoriasis complications, what milia is and more!

A preview at what to expect from Dermatology Times this week.

ICYMI, some of this week’s featured content includes an exclusive interview about eczema, and articles on a new tralokinumab data, apremilast as a combination treatment, and more.

This week’s edition of The Mainstream Patient features stories about how biologic treatments changed 6 psoriasis patients lives, updated sunscreen regulations, and more!

A preview at what to expect from Dermatology Times this week.

ICYMI, some of this week’s featured content includes an exclusive interview about tralokinumab, and articles on ruxolitinib as a treatment for vitiligo, the role of diet in acne and more.

Bayer is recalling its Lotrimin AF and Tinactin spray products due to the presence of the carcinogen benzene.

Coppertone, David Light, founder and CEO of Valisure, and Christopher Bunick, MD, PhD, share their thoughts on the sunscreen giant’s voluntary recall of 12 lots of its aerosol sunscreen after finding the presence of benzene.

In this month's Cosmetic Conundrums column, Dermatology Times® Chief Medical Editor Zoe Diana Draelos, MD, explore skin and hair diversity, including physiological and characteristic differences.

The two companies are using their DREAM initiative to support the diverse dermatology index.

In this month's Legal Eagle column, David J. Goldberg, MD, JD, addresses the question of what private practice dermatologist have to consider with Covid-19 vaccines.